BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23299156)

  • 1. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM; Kordofani AA; Fadl-Elmula IM
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
    Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
    Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
    Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
    Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
    Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R; Ahmad I; Javid J; Zuberi M; Yadav P; Shazia R; Masroor M; Guru S; Ray PC; Gupta N; Saxena A
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
    Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India.
    Sazawal S; Chhikara S; Singh K; Chaubey R; Mahapatra M; Seth T; Saxena R
    Indian J Pathol Microbiol; 2019; 62(2):256-260. PubMed ID: 30971550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.
    Khazaal MS; Hamdan FB; Al-Mayah QS
    Mol Genet Genomic Med; 2019 Aug; 7(8):e809. PubMed ID: 31206255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
    Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
    Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of p210 BCR-ABL transcript variants with clinical, parameters and disease outcome in 45 chronic myeloid leukemia patients.
    Al-Achkar W; Moassass F; Youssef N; Wafa A
    J BUON; 2016; 21(2):444-9. PubMed ID: 27273956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
    Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
    J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran.
    Ayatollahi H; Keramati MR; Shirdel A; Kooshyar MM; Raiszadeh M; Shakeri S; Sadeghian MH
    Caspian J Intern Med; 2018; 9(1):65-70. PubMed ID: 29387322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients.
    Osman EA; Hamad K; Elmula IM; Ibrahim ME
    Genet Mol Biol; 2010 Apr; 33(2):229-31. PubMed ID: 21637474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia.
    de Lemos JA; de Oliveira CM; Scerni AC; Bentes AQ; Beltrão AC; Bentes IR; Azevedo TC; Maradei-Pereira LM
    Genet Mol Res; 2005 Dec; 4(4):803-11. PubMed ID: 16475128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
    Sharma P; Kumar L; Mohanty S; Kochupillai V
    Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.